Yuedan gained her PhD in cell physiology from the Radboud University Nijmegen Medical Center in The Netherlands. During her studies, she specialized in studying the different acquired and genetic forms of nephrogenic diabetes insipidus and their treatments. For her postdoctoral work, she researched new stem cell therapies for genetic disorders.
In 2013 she joined Percuros and is currently involved in projects related to the development of the biomarker assays, immunotherapies and molecular imaging tools.
Yuedan is the project manager for ELECTOR WP3 within Percuros. Her vast experience in management and diverse skills in the laboratory makes her an outstanding choice for this role, which helps to link up the work and the deliverables of Atonomics and Percuros.
Alan has more than 25 years management experience in science and technology companies.
Dr Alan Chan was co-founder, Vice President of Research and Chairman of the scientific advisory board of biotech company, PamGene from 2000 - 2005.
In 2005, he founded Percuros where he still works in the lab to offer hands-on expertise in optical imaging of brain, tumour immunology, regenerative medicine and skeletal biology events.
Alan is currently the coordinator of several EU- and Dutch-funded projects, including the EU Marie Curie IAPP project BRAINPATH on molecular imaging of brain pathophysiology, involving training of 21 researchers across Europe, the EU Marie Curie RISE project PRISAR on preclinical intraoperative image-guided surgery and postoperative radiotherapy of tumours, involving training of 48 researchers across Europe, and a EU Marie Curie ITN project, ISPIC, which involves training of 19 early stage researchers.
Under his lead, Percuros also contributed to the Dutch-funded projects, IMPACT, studying photodynamic therapy and CTMM MUSIS on clinical translation of image-guided surgery.
the European Union